FDA Orange Book
Generic for Dilaudid
Dilaudid contains hydromorphone. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Dilaudid is hydromorphone. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AA, AB, AP. Generics match 8 of the 9 Dilaudid products the Orange Book lists.
Run it in Rivvi
Map Dilaudid and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Dilaudid products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | 0.2MG/ML | Marketed (Rx) | AP | 1 | AP |
| injectable, injection | 0.5MG/0.5ML | Marketed (Rx) | AP | 1 | AP |
| injectable, injection | 1MG/ML | Marketed (Rx) | AP | 1 | AP |
| injectable, injection | 2MG/ML | Marketed (Rx) | AP | 2 | AP |
| injectable, injection | 4MG/ML | Marketed (Rx) | AP | 0 | None |
| solution, oral | 5MG/5ML | Marketed (Rx) | AA | 2 | AA |
| tablet, oral | 2MG | Marketed (Rx) | AB | 3 | AB |
| tablet, oral | 4MG | Marketed (Rx) | AB | 3 | AB |
| tablet, oral | 8MG | Marketed (Rx) | AB | 3 | AB |
NDA 019034, 019891, 019892, held by FRESENIUS KABI USA LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic hydromorphone
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | 074653 | AA (A-rated, therapeutically equivalent) | July 29, 1998 | 5MG/5ML |
| SPECGX LLC | 076855 | AB (A-rated, therapeutically equivalent) | September 19, 2007 | 2MG, 4MG, 8MG |
| AUROLIFE PHARMA LLC | 205814 | AB (A-rated, therapeutically equivalent) | May 13, 2016 | 2MG, 4MG, 8MG |
| ASCENT PHARMACEUTICALS INC | 210176 | AA (A-rated, therapeutically equivalent) | October 27, 2017 | 5MG/5ML |
| ASCENT PHARMACEUTICALS INC | 210506 | AB (A-rated, therapeutically equivalent) | January 17, 2018 | 2MG, 4MG, 8MG |
| HIKMA PHARMACEUTICALS USA INC | 202159 | AP (A-rated, therapeutically equivalent) | April 27, 2018 | 2MG/ML |
| HIKMA PHARMACEUTICALS USA INC | 216899 | AP (A-rated, therapeutically equivalent) | February 9, 2024 | 0.2MG/ML, 0.5MG/0.5ML, 1MG/ML, 2MG/ML |
Dilaudid patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9731082 | April 23, 2032 | Drug product | None | 019034 |
| 9248229 | March 12, 2034 | Drug product | None | 019034 |
Dilaudid NDC codes
Questions
Is there a generic for Dilaudid?
Yes. The generic name for Dilaudid is hydromorphone. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AA, AB, AP. Generics match 8 of the 9 Dilaudid products the Orange Book lists.
What is the generic name for Dilaudid?
The active ingredient in Dilaudid is hydromorphone, per the FDA Orange Book.
When does the Dilaudid patent expire?
The last patent listed for Dilaudid in the Orange Book expires March 12, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Dilaudid and Hydromorphone
- What is Dilaudid used for?FDA label uses
- Is Dilaudid a controlled substance?Schedule II
- What is Hydromorphone used for?FDA label uses
- Is Hydromorphone a controlled substance?Schedule II
- Generic for Dilaudid-hpFDA Orange Book
- Generic for ExalgoFDA Orange Book
- Opioid Agonists listFDA drug class
- NDC 42858-122Dilaudid NDC record
- NDC 42858-234Dilaudid NDC record
- NDC 42858-338Dilaudid NDC record
- Schedule II drugs listDEA schedule